Cornerstone Wealth Group LLC Buys 190 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cornerstone Wealth Group LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.6% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 12,230 shares of the healthcare conglomerate’s stock after purchasing an additional 190 shares during the period. Cornerstone Wealth Group LLC’s holdings in UnitedHealth Group were worth $6,187,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of UNH. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group during the third quarter worth approximately $27,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at $30,000. Global Wealth Strategies & Associates increased its holdings in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. West Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth about $32,000. Finally, Quarry LP grew its stake in UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 37 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Barclays decreased their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. KeyCorp reissued an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. TD Cowen boosted their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $627.74.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $532.26 on Monday. The stock’s 50-day moving average is $541.04 and its 200-day moving average is $564.34. The stock has a market cap of $489.83 billion, a P/E ratio of 34.34, a price-to-earnings-growth ratio of 1.41 and a beta of 0.62. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.83 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.58%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.